Completed
To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients
NCT01069926
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Lowering, +3 more
- Locations
-
- Research Site Orlando, Florida, United States
- Research Site Overland Park, Kansas, United States
- Research Site Minneapolis, Minnesota, United States
- Research Site Knoxville, Tennessee, United States